ATE74662T1 - Immunoanalysetestverfahren fuer cholesterolepoxide. - Google Patents
Immunoanalysetestverfahren fuer cholesterolepoxide.Info
- Publication number
- ATE74662T1 ATE74662T1 AT85906115T AT85906115T ATE74662T1 AT E74662 T1 ATE74662 T1 AT E74662T1 AT 85906115 T AT85906115 T AT 85906115T AT 85906115 T AT85906115 T AT 85906115T AT E74662 T1 ATE74662 T1 AT E74662T1
- Authority
- AT
- Austria
- Prior art keywords
- immunoanalytic
- cholesterolepoxide
- test procedure
- hapten
- immunoassay
- Prior art date
Links
- PRYIJAGAEJZDBO-ZEQHCUNVSA-N 5,6alpha-epoxy-5alpha-cholestan-3beta-ol Chemical compound C([C@]12O[C@H]1C1)[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 PRYIJAGAEJZDBO-ZEQHCUNVSA-N 0.000 title abstract 3
- 238000010998 test method Methods 0.000 title 1
- 238000003018 immunoassay Methods 0.000 abstract 2
- 102000014914 Carrier Proteins Human genes 0.000 abstract 1
- 108010078791 Carrier Proteins Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/003—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/961—Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
- Y10S436/817—Steroids or hormones
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/822—Identified hapten
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/823—Immunogenic carrier or carrier per se
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Steroid Compounds (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/673,768 US4639420A (en) | 1984-11-21 | 1984-11-21 | Method for the immunoanalysis of cholesterol epoxides |
| PCT/US1985/002274 WO1986003299A1 (en) | 1984-11-21 | 1985-11-20 | Method for immunoanalysis of cholesterol epoxides |
| EP85906115A EP0203968B1 (de) | 1984-11-21 | 1985-11-20 | Immunoanalysetestverfahren für cholesterolepoxide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE74662T1 true ATE74662T1 (de) | 1992-04-15 |
Family
ID=24704047
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT85906115T ATE74662T1 (de) | 1984-11-21 | 1985-11-20 | Immunoanalysetestverfahren fuer cholesterolepoxide. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4639420A (de) |
| EP (1) | EP0203968B1 (de) |
| JP (1) | JPS62501446A (de) |
| AT (1) | ATE74662T1 (de) |
| CA (1) | CA1250831A (de) |
| DE (1) | DE3585834D1 (de) |
| WO (1) | WO1986003299A1 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4859613A (en) * | 1986-11-12 | 1989-08-22 | Lawrence David A | Immunoassays for glutathione and antibodies useful therein |
| US5629023A (en) * | 1991-12-31 | 1997-05-13 | Bland; Jeffrey S. | Medical food composition for metabolic detoxification |
| IL146223A0 (en) * | 1999-04-30 | 2002-07-25 | Arch Dev Corp | Steroid derivatives |
| US6770468B1 (en) | 1999-09-14 | 2004-08-03 | Genzyme Glycobiology Research Institute, Inc. | Phosphodiester-α-GlcNAcase of the lysosomal targeting pathway |
| US6534300B1 (en) | 1999-09-14 | 2003-03-18 | Genzyme Glycobiology Research Institute, Inc. | Methods for producing highly phosphorylated lysosomal hydrolases |
| CN1498222A (zh) * | 2001-02-08 | 2004-05-19 | 芝加哥大学 | 类固醇衍生物 |
| US7078396B2 (en) * | 2001-05-03 | 2006-07-18 | Arch Development Corporation | Method of treating disorder related to high cholesterol concentration |
| DK1392713T3 (da) * | 2001-05-03 | 2008-02-18 | Univ Chicago | Lever-X-receptoragonister |
| US20070197484A1 (en) * | 2001-05-03 | 2007-08-23 | Ching Song | Method of treating disorder related to high cholesterol concentration |
| US20030124652A1 (en) * | 2001-12-21 | 2003-07-03 | Novazyme Pharmaceuticals, Inc. | Methods of producing high mannose glycoproteins in complex carbohydrate deficient cells |
| US6905856B2 (en) * | 2001-12-21 | 2005-06-14 | Genzyme Glycobiology Research Institute, Inc. | Soluble GlcNAc phosphotransferase |
| US6800472B2 (en) * | 2001-12-21 | 2004-10-05 | Genzyme Glycobiology Research Institute, Inc. | Expression of lysosomal hydrolase in cells expressing pro-N-acetylglucosamine-1-phosphodiester α-N-acetyl glucosimanidase |
| CA2482195A1 (en) * | 2002-04-12 | 2003-10-23 | The University Of Chicago | Farnesoid x-activated receptor agonists |
| FR2838741B1 (fr) | 2002-04-19 | 2006-01-27 | Inst Nat Sante Rech Med | Derives de sterols, leur procede de preparation et medicaments les comportant |
| ATE485818T1 (de) * | 2002-07-30 | 2010-11-15 | Karykion Inc | Zusammensetzungen aus ezetimib und verfahren zur behandlung von mit cholesterin zusammenhängenden gutartigen und bösartigen tumoren |
| US20070032464A1 (en) * | 2004-10-08 | 2007-02-08 | Shutsung Liao | Methods of treating cancers |
| EP2459581A4 (de) * | 2009-07-29 | 2012-12-26 | Univ Chicago | Leber x-rezeptor-agonisten |
| US20200048305A1 (en) * | 2018-08-10 | 2020-02-13 | South Dakota Board Of Regents | Glutathione-cholesterol derivatives as brain targeting agents |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1364922A (en) * | 1970-06-11 | 1974-08-29 | Gross S J | Materials for immunochemical assaying |
| DE3319066A1 (de) * | 1983-05-26 | 1984-11-29 | Claus-Christian Dr.Rer.Nat. Dr.Med. 6901 Wilhelmsfeld Heuck | Verfahren und reagenz zum direkten nachweis eines analyts nach spezifischer entfernung von colloidpartikeln in waessrigen loesungen biologischer herkunft |
-
1984
- 1984-11-21 US US06/673,768 patent/US4639420A/en not_active Expired - Fee Related
-
1985
- 1985-11-20 DE DE8585906115T patent/DE3585834D1/de not_active Expired - Lifetime
- 1985-11-20 WO PCT/US1985/002274 patent/WO1986003299A1/en not_active Ceased
- 1985-11-20 EP EP85906115A patent/EP0203968B1/de not_active Expired
- 1985-11-20 AT AT85906115T patent/ATE74662T1/de not_active IP Right Cessation
- 1985-11-20 CA CA000495724A patent/CA1250831A/en not_active Expired
- 1985-11-20 JP JP60505371A patent/JPS62501446A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO1986003299A1 (en) | 1986-06-05 |
| EP0203968B1 (de) | 1992-04-08 |
| CA1250831A (en) | 1989-03-07 |
| US4639420A (en) | 1987-01-27 |
| EP0203968A1 (de) | 1986-12-10 |
| DE3585834D1 (de) | 1992-05-14 |
| EP0203968A4 (de) | 1989-06-14 |
| JPS62501446A (ja) | 1987-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE74662T1 (de) | Immunoanalysetestverfahren fuer cholesterolepoxide. | |
| FI891012A0 (fi) | Menetelmä ja väline immuunikokeissa esiintyvien häiriötekijöiden kompensoimiseksi | |
| JPS5763454A (en) | Immuno assay method and assay apparatus | |
| ATE1614T1 (de) | Immunologisches bestimmungsverfahren. | |
| SE7702465L (sv) | Sett vid bestemningsmetoder involverande biospecifika affinitetsreaktioner | |
| ES8606653A1 (es) | Un metodo para la preparacion de una proteina que esta cova-lentemente acoplada a un extremo de un acido nucleico | |
| NO885808D0 (no) | Fremgangsmaate for oppnaaelse av en lineaer standardkurve i en sandwich-immunoanalyse. | |
| DE3486356D1 (de) | Von polypeptiden induzierte monoklonale antikörper gegen oncoproteine. | |
| NZ237535A (en) | Carrier for binding anti-phospholipid antibodies, its use in immunoassays and kits and blood protein which enhances binding ability of antiphospholipid antibody | |
| ES512498A0 (es) | "metodo y su correspondiente aparato para el ensayo de anticuerpos con respecto a antigenos solubles". | |
| DE3576854D1 (de) | Immunchemisches messverfahren fuer haptene und proteine. | |
| KR850002385A (ko) | PIVKA-Ⅱ의 측정(assay)용 방법 및 시약 | |
| DE3781582D1 (de) | Verfahren und reagenz zur bestimmung eines reaktionspartners einer immunologischen reaktion. | |
| EP0088974A3 (de) | Homogenes immunologisches Verfahren mit markiertem, monoclonalem Antianalyten | |
| ES8501530A1 (es) | Metodo de ensayo de anticuerpos. | |
| DE3785567D1 (de) | Immunologischer testkit. | |
| DE3686717D1 (de) | Immuntestverfahren. | |
| IL77862A (en) | Enzymatic immunoassay to determine the amount of antibodies to htlv-iii and test kit | |
| DE3273844D1 (en) | Procedure for immunological determinations using two antibodies, the second antibody being purified by affinity chromatography, and supports therefor | |
| SE8304190D0 (sv) | Forfarande och reagens for immunologiska metningar | |
| ES2076221T3 (es) | Derivados geminales de difenilo y su uso en inmunoensayos. | |
| DK414386D0 (da) | Monoklonalt antistof, cellelinje til fremstilling deraf og antistoffets anvendelse | |
| DE59207717D1 (de) | Verfahren zur Bestimmung einer immunologisch bindefähigen Substanz | |
| DE3569161D1 (en) | Process for assaying atl virus antibody and reagent therefore | |
| DE3365111D1 (en) | Labelled conjugates of ethosuximide, ethosuximide immunogens, antibodies thereto, immunoassay method employing the antibodies and reagent means, test kit and test device for the immunoassay method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |